4.6 Article

Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease

期刊

THROMBOSIS AND HAEMOSTASIS
卷 106, 期 5, 页码 885-892

出版社

GEORG THIEME VERLAG KG
DOI: 10.1160/TH11-03-0180

关键词

Bleeding; menorrhagia; postpartum haemorrhage; von Willebrand disease; hysterectomy

资金

  1. Dutch Hemophilia Foundation
  2. CSL Behring
  3. Bayer Schering Pharma
  4. Baxter
  5. ZLB Behring
  6. Novo Nordisk
  7. Wyeth

向作者/读者索取更多资源

A nation-wide cross-sectional study was initiated to assess gynaecological and obstetrical symptoms in an unselected cohort of women with moderate and severe von Willebrand disease (VWD) in the Netherlands. A total of 423 women aged >= 16 years were included. Bleeding severity was measured using the Tosetto Bleeding Score (BS). Menorrhagia, defined as occurrence of >= 2 menorrhagia symptoms, was reported by 81%. Of all VWD women, 78% received any kind of treatment for menorrhagia and 20% underwent a hysterectomy predominantly because of severe menstrual bleeding. Over half of the women reported more blood loss than can be expected with a normal delivery. In 52% of reported pregnancy losses curettage was needed because of bleeding. Mean number of live births was 1.9, which is comparable with the general Dutch population. In conclusion, women with moderate or severe VWD frequently have menorrhagia in need of treatment, and 20% of the VWD women underwent a hysterectomy. Bleeding complications occurred in over 50% of the women after childbirth or pregnancy loss. Progeny seems not to be affected in women with moderate or severe VWD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据